Prof. Dr. Ilteris Oguz

Prof. Dr. Ilteris Oguz
Academic Title :
Prof. Dr.

Prof. Dr. Ilteris Oguz is a prominent specialist in Dermatology at Liv Hospital Ulus in Istanbul, with a distinguished clinical and academic career spanning over two decades in diagnosing and treating skin conditions and cosmetic concerns.

Education and Academic Qualifications

  • Medical Degree from Istanbul University, Istanbul Faculty of Medicine (1996 - 2002)
  • Specialization in Dermatology and Venereology from Sisli Etfal Training and Research Hospital, University of Health Sciences (2002 - 2008)
  • Turkish Board Certification in Dermatology (2017)

Areas of Interest

  • Treatment of psoriasis and urticaria
  • Treatment of acne and rosacea
  • Management of genital HPV infections and warts
  • Treatment of hair loss and scalp disorders in Turkey
  • Nevus (mole) follow-up and skin cancer screening
  • Dermatological surgery and lesion removal
  • Cosmetic dermatology, including botulinum toxin and filler injections
  • Mesotherapy and Platelet-Rich Plasma (PRP) therapies
  • Stem cell and exosome treatments for skin rejuvenation
  • Anti-aging and wrinkle reduction programs
  • Treatment of skin pigmentation, blemishes, and therapeutic laser applications
  • Specialist Dermatologist at Batman Regional Hospital as part of compulsory medical service (2008 - 2010)
  • Chief Assistant and subsequent Associate Professor at Okmeydanı Training and Research Hospital (2010 - 2019)
  • Associate Professor and Educational/Administrative Officer of the Dermatology Department at Prof. Dr. Cemil Tascioglu City Hospital (2019 - 2025)
  • Professor and Faculty Member at Istinye University, Faculty of Medicine (2025 - Present)
  • Professor and Specialist Dermatologist at Liv Hospital Ulus in Istanbul (2025 - Present)
  • Turkish Society of Dermatology (Member of the Psoriasis Working Group)
  • Skin and Venereal Diseases Association (Substitute Board Member for the 2019 - 2021 term)
  • Author of the medical book 'Immunomodulatory and Immunosuppressive Drugs in Dermatology' (2016)
  • Drug survival and safety profile of acitretin monotherapy in patients with psoriasis: A multicenter retrospective study (Published in Dermatologic Therapy, 2021)
  • Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: Real-world data from a retrospective multicenter study (Published in Anais Brasileiros de Dermatologia, 2022)
  • The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul (Published in Dermatologic Therapy, 2021)
  • A Case of Linear Scleroderma En Coup de Sabre Accompanied with Migraine with Visual Aura and Idiopathic Intracranial Hypertension (Published in Indian Journal of Dermatology, 2023)
Share :